Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C with Steroids for First Line Therapy of Gastrointestinal GVHD
NCT07197749Phase 1Not yet recruiting
- Sponsor
- Baylor College of Medicine
- Start
- Nov 2026
- Primary completion
- Oct 2028
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of ascorbic acid in graft-versus-host disease (GVHD), sponsored by Baylor College of Medicine. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
ascorbic acid
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT07197749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07197749.